Free National NPI Number Registry
Majid Mani
Home > Majid Mani
NPI Number Detailed Information
Provider Information:
| Name: | Majid Mani |
| Gender: | M |
| Provider License Number If Given: | A60640 |
NPI Information:
| NPI: | 1043261373 |
| Entity Type (Individual or Organization): |
1-ind |
| Enumeration Date: | 5/12/2006 |
| Last Update Date: | 4/5/2017 |
| Reputation Report: |
Provider Business Mailing Address:
| Address: | 835 THIRD AVE SUITE A Chula Vista, CA 91911 |
| Phone Number: | 6194257755 |
| Fax Number: | 6194259057 |
Provider Business Practice Location Address:
| Address: | 835 THIRD AVE SUITE A Chula Vista, CA 91911 |
| Phone Number: | 6194257755 |
| Fax Number: | 6194259057 |
Provider Taxonomy:
| Primary: | 207W00000X |
| Secondary (if any): | 207WX0107X |
| State: | CA |
Top Doctors in CA
About Majid Mani
Majid Mani ( MAJID MANI ) is An Ophthalmology Physician in Chula Vista, CA.
The NPI Number for Majid Mani is 1043261373.
The current location address for Majid Mani is 835 THIRD AVE SUITE A Chula Vista, CA 91911 and the contact number is 6194257755 and fax number is 6194259057.
The mailing address for Majid Mani is 835 THIRD AVE SUITE A Chula Vista, CA 91911- 6194257755 (mailing address contact number - 6194257755).
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Provider Business Location on Map
FAQs:
What is the NPI Number for Majid Mani ?
Answer: The NPI Number for Majid Mani is 1043261373
Where is Majid Mani located?
Answer: Majid Mani is located at 835 THIRD AVE SUITE A Chula Vista, CA 91911.
What is the specialty for Majid Mani ?
Answer: The Specialty of Majid Mani is An Ophthalmology Physician.
Are there any online reviews for Majid Mani ?
Answer: Yes! Check It Now.
Are there any other health care providers in Chula Vista, CA?
Answer: Yes, there are given below...
Medicare Physician & Other Practitioners
Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Majid Mani
Medicare Part D Prescribers
Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.
| Provider Specialty Type | Ophthalmology |
| Source of Provider Specialty | |
| Number of Medicare Part D Claims, Including Refills | 4537 |
| Number of Standardized 30-Day Fills | 6217.1666667 |
| Aggregate Cost Paid for All Claims | 468825.21 |
| Number of Day's Supply for All Claims | 170744 |
| Number of Medicare Beneficiaries | 937 |
| Number of Claims, Including Refills, for Beneficiaries Age 65+ | 4131 |
| Including Refills, for Beneficiaries Age 65+ | 5670.4666667 |
| Beneficiaries Age 65+ | 447467.58 |
| Number of Day's Supply for All Claims for Beneficaries Age 65+ | 155861 |
| Number of Medicare Beneficiaries Age 65+ | 853 |
| Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst | |
| Total Claims of Brand-Name Drugs | 1491 |
| Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst | |
| Total Claims of Generic Drugs, Including Refills | 3046 |
| Aggregate Cost Paid for Generic Drugs | 99885.78 |
| Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst | |
| Total Claims of Other Drugs, Including Refills | 0 |
| Aggregate Cost Paid for Other Drugs | 0 |
| Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by MAPD Plans | 1225 |
| Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans | 77961.75 |
| Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Standalone PDP Plans | 3312 |
| Aggregate Cost Paid for Claims Filled by | 390863.46 |
| Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst | |
| Number of Claims for Beneficiaries Covered by Low-Income Subsidy | 3519 |
| Aggregate Cost Paid for Claims Covered by Low-Income Subsidy | 406669.11 |
| Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst | |
| Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy | 1018 |
| by Low-Income Subsidy | 62156.1 |
| Total Claims of Opioid Drugs, Including | |
| Aggregate Cost Paid for Opioid Drugs | |
| Opioid Claims | |
| Opioid_Tot_Clms divided by the Tot_Clms | |
| Total Claims of Long-Acting Opioid Drugs | |
| Aggregate Cost Paid for Long-Acting Opioid | |
| Number of Day's Supply of All Long-Acting | |
| Long-Acting Opioid Claims | |
| Opioid_LA_Tot_Clms divided by the | |
| Total Claims of Antibiotic Drugs, Including | 11 |
| Aggregate Cost Paid for Antibiotic Drugs | 67.95 |
| Antibiotic Claims | |
| Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst | |
| Including Refills, for Beneficiaries Age 65+ | 0 |
| Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ | 0 |
| Reason for Suppression of Antpsyct_GE65_Tot_Benes | |
| Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims | 0 |
| Average Age of Beneficiaries | 74.935965848 |
| Number of Beneficiaries Age Less Than 65 | 84 |
| Number of Beneficiaries Age 65 to 74 | 378 |
| Number of Beneficiaries Age 75 to 84 | 315 |
| Number of Female Beneficiaries | 557 |
| Number of Male Beneficiaries | 380 |
| Number of Non-Hispanic White | 92 |
| Number of Black or African American | 12 |
| Number of Asian Pacific Islander | 12 |
| Number of Hispanic Beneficiaries | 814 |
| Number of American Indian/Alaskan NativeBeneficiaries | |
| Number of Beneficiaries with Race Not | |
| Only Entitlement | 269 |
| Average Hierarchical Condition Category | 1.9712267978 |
More Providers in chula-vista , ca
majid mani in Other Directories
Provider don't have other directory link yet.